Form D · Biotechnology
SV-MEDTECH Inc.
Livermore, CA · CIK 0001730541
Offering snapshot reported May 15, 2018 · SEC filing
- Reported sold
- $600K Offering amount: $600K
- Investors reported
- 17 Form D · investor count
- Minimum accepted
- $10K Reported outside-investor minimum
- First sale
- Mar 30, 2018 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 15, 2018 | Initial | $600,000 | No comparison | 17 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06c, 4a5
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-312469
Source: Form D, filed May 15, 2018. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Troy Barring | Director |
| Joseph Jamello | Director |
| Shawn Moaddeb | Director |
| Thomas Charles Moore | Director, Executive |
| Kendall Waters | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
220 Wright Brothers Avenue Suite B
Livermore, CA, 94551
Livermore, CA, 94551